Genomic
Health, Inc
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.0001 per share
|
||||
(Title
of Class of Securities)
|
||||
37244C101
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 17th Floor
New
York, NY 10021
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices
and
Communications)
|
||||
February
13, 2007
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 37244C101
|
Page
2
of 9
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian
C. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
o
(b)
x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
||||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
2,625,229
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
2,625,229
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,625,229
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
x
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.7%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 37244C101
|
Page
3
of 9
Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix
J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
o
(b)
x
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d)
OR 2(e)
|
||||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
2,625,229
|
|||
8
|
SHARED
VOTING POWER
2,625,229
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
2,625,229
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,625,229
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
x
|
|||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.7%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Name
|
Business
Address
|
Present
Principal Occupation
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10021
|
Managing
Member, Baker Bros. Advisors, LLC (an entity engaged in investment
activities)
|
Percent
of class
|
|||
Name
|
Number
of Shares
|
Outstanding
|
|
Baker
Bros. Investments, L.P.
|
173,897
|
0.7
|
%
|
Baker
Bros. Investments II, L.P.
|
15,949
|
0.1
|
%
|
Baker
Biotech Fund I, L.P.
|
524,589
|
2.1
|
%
|
Baker
Brothers Life Sciences, L.P.
|
1,516,006
|
6.2
|
%
|
14159,
L.P.
|
31,385
|
0.1
|
%
|
Baker/Tisch
Investments, L.P.
|
189,506
|
0.8
|
%
|
FBB
Associates
|
173,897
|
0.7
|
%
|
Total
|
2,625,229
|
10.7
|
%
|
Name
|
Date
|
Number
of Shares
|
Transaction
|
Price/
Share
|
14159,
L.P.
|
12/1/2006
|
10,235
|
Purchase
|
20.4106
|
Baker
Biotech Fund I, L.P.
|
12/1/2006
|
111,763
|
Purchase
|
20.4106
|
Baker
Brothers Life Sciences, L.P.
|
12/1/2006
|
312,103
|
Purchase
|
20.4106
|
Baker/
Tisch Investments, L.P.
|
12/1/2006
|
5,860
|
Purchase
|
20.4106
|
14159,
L.P.
|
12/1/2006
|
100
|
Purchase
|
18.9883
|
Baker
Biotech Fund I, L.P.
|
12/1/2006
|
1,093
|
Purchase
|
18.9883
|
Baker
Brothers Life Sciences, L.P.
|
12/1/2006
|
3,050
|
Purchase
|
18.9883
|
Baker/
Tisch Investments, L.P.
|
12/1/2006
|
57
|
Purchase
|
18.9883
|
14159,
L.P.
|
12/1/2006
|
109
|
Purchase
|
18.9511
|
Baker
Biotech Fund I, L.P.
|
12/1/2006
|
1,194
|
Purchase
|
18.9511
|
Baker
Brothers Life Sciences, L.P.
|
12/1/2006
|
3,334
|
Purchase
|
18.9511
|
Baker/
Tisch Investments, L.P.
|
12/1/2006
|
63
|
Purchase
|
18.9511
|
14159,
L.P.
|
12/1/2006
|
533
|
Purchase
|
20.7890
|
Baker
Biotech Fund I, L.P.
|
12/1/2006
|
5,828
|
Purchase
|
20.7890
|
Baker
Brothers Life Sciences, L.P.
|
12/1/2006
|
16,273
|
Purchase
|
20.7890
|
Baker/
Tisch Investments, L.P.
|
12/1/2006
|
306
|
Purchase
|
20.7890
|
14159,
L.P.
|
12/1/2006
|
1,512
|
Purchase
|
19.0000
|
Baker
Biotech Fund I, L.P.
|
12/1/2006
|
16,512
|
Purchase
|
19.0000
|
Baker
Brothers Life Sciences, L.P.
|
12/1/2006
|
46,110
|
Purchase
|
19.0000
|
Baker/
Tisch Investments, L.P.
|
12/1/2006
|
866
|
Purchase
|
19.0000
|
14159,
L.P.
|
12/4/2006
|
306
|
Purchase
|
20.3849
|
Baker
Biotech Fund I, L.P.
|
12/4/2006
|
3,336
|
Purchase
|
20.3849
|
Baker
Brothers Life Sciences, L.P.
|
12/4/2006
|
9,316
|
Purchase
|
20.3849
|
Baker/
Tisch Investments, L.P.
|
12/4/2006
|
175
|
Purchase
|
20.3849
|
14159,
L.P.
|
12/4/2006
|
790
|
Purchase
|
20.7789
|
Baker
Biotech Fund I, L.P.
|
12/4/2006
|
8,644
|
Purchase
|
20.7789
|
Baker
Brothers Life Sciences, L.P.
|
12/4/2006
|
24,137
|
Purchase
|
20.7789
|
Baker/
Tisch Investments, L.P.
|
12/4/2006
|
454
|
Purchase
|
20.7789
|
14159,
L.P.
|
12/5/2006
|
2,295
|
Purchase
|
22.5462
|
Baker
Biotech Fund I, L.P.
|
12/5/2006
|
25,071
|
Purchase
|
22.5462
|
Baker
Brothers Life Sciences, L.P.
|
12/5/2006
|
70,010
|
Purchase
|
22.5462
|
Baker/
Tisch Investments, L.P.
|
12/5/2006
|
1,315
|
Purchase
|
22.5462
|
14159,
L.P.
|
12/6/2006
|
1,120
|
Purchase
|
21.5823
|
Baker
Biotech Fund I, L.P.
|
12/6/2006
|
12,237
|
Purchase
|
21.5823
|
Baker
Brothers Life Sciences, L.P.
|
12/6/2006
|
34,173
|
Purchase
|
21.5823
|
Baker/
Tisch Investments, L.P.
|
12/6/2006
|
642
|
Purchase
|
21.5823
|
Baker
Bros. Investments II, L.P.
|
2/12/2007
|
49
|
Purchase
|
17.8925
|
14159,
L.P.
|
2/12/2007
|
691
|
Purchase
|
17.8925
|
Baker
Biotech Fund I, L.P.
|
2/12/2007
|
8,039
|
Purchase
|
17.8925
|
Baker
Brothers Life Sciences, L.P.
|
2/12/2007
|
21,742
|
Purchase
|
17.8925
|
Baker/
Tisch Investments, L.P.
|
2/12/2007
|
449
|
Purchase
|
17.8925
|
Baker
Bros. Investments II, L.P.
|
2/13/2007
|
373
|
Purchase
|
18.2575
|
14159,
L.P.
|
2/13/2007
|
5,323
|
Purchase
|
18.2575
|
Baker
Biotech Fund I, L.P.
|
2/13/2007
|
61,735
|
Purchase
|
18.2575
|
Baker
Brothers Life Sciences, L.P.
|
2/13/2007
|
166,962
|
Purchase
|
18.2575
|
Baker/
Tisch Investments, L.P.
|
2/13/2007
|
3,445
|
Purchase
|
18.2575
|
14159,
L.P.
|
2/14/2007
|
5
|
Purchase
|
18.4300
|
Baker
Biotech Fund I, L.P.
|
2/14/2007
|
52
|
Purchase
|
18.4300
|
Baker
Brothers Life Sciences, L.P.
|
2/14/2007
|
140
|
Purchase
|
18.4300
|
Baker/
Tisch Investments, L.P.
|
2/14/2007
|
3
|
Purchase
|
18.4300
|
Baker
Bros. Investments II, L.P.
|
2/14/2007
|
157
|
Purchase
|
18.3600
|
14159,
L.P.
|
2/14/2007
|
2,237
|
Purchase
|
18.3600
|
Baker
Biotech Fund I, L.P.
|
2/14/2007
|
25,957
|
Purchase
|
18.3600
|
Baker
Brothers Life Sciences, L.P.
|
2/14/2007
|
70,200
|
Purchase
|
18.3600
|
Baker/
Tisch Investments, L.P.
|
2/14/2007
|
1,449
|
Purchase
|
18.3600
|
Baker
Bros. Investments II, L.P.
|
2/16/2007
|
1
|
Purchase
|
18.4300
|
14159,
L.P.
|
2/16/2007
|
19
|
Purchase
|
18.4300
|
Baker
Biotech Fund I, L.P.
|
2/16/2007
|
212
|
Purchase
|
18.4300
|
Baker
Brothers Life Sciences, L.P.
|
2/16/2007
|
574
|
Purchase
|
18.4300
|
Baker/
Tisch Investments, L.P.
|
2/16/2007
|
12
|
Purchase
|
18.4300
|
Baker
Bros. Investments II, L.P.
|
2/16/2007
|
55
|
Purchase
|
18.5432
|
14159,
L.P.
|
2/16/2007
|
792
|
Purchase
|
18.5432
|
Baker
Biotech Fund I, L.P.
|
2/16/2007
|
9,184
|
Purchase
|
18.5432
|
Baker
Brothers Life Sciences, L.P.
|
2/16/2007
|
24,838
|
Purchase
|
18.5432
|
Baker/
Tisch Investments, L.P.
|
2/16/2007
|
513
|
Purchase
|
18.5432
|
By:
|
/s/
Julian C. Baker
|
|
|
Julian
C. Baker
|
|
By:
|
/s/
Felix J. Baker
|
|
|
Felix
J. Baker
|
By:
|
/s/
Julian C. Baker
|
|
Julian
C. Baker
|
||
By:
|
/s/
Felix J. Baker
|
|
Felix
J. Baker
|